Medicine News

• Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Pro ...
  Fri, 26 February 2010
  Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2-391 in patients with bone-metastatic, castrate-resistant prostate cancer (CRPC) who have not had prior chemotherapy...
• Light Sciences Oncology Meets A Major Milestone In Aptocine Development With Target Enro ...
  Fri, 26 February 2010
  Light Sciences Oncology, Inc. (LSO) announced the achievement of a major milestone in its late-stage clinical development of Aptocine? (talaporfin sodium) for treatment of solid tumors. LSO's global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites...
• History And Future Of Laser Technology Highlighted At 2010 AAAS Annual Meeting
  Fri, 26 February 2010
  As part of LaserFest, the year-long celebration of the 50th anniversary of the first working laser, the Optical Society (OSA) and the American Physical Society (APS) sponsored a special day-long seminar on the birth, growth and future developments in laser science and technology at the 2010 American Association for the Advan ...
• Efficient Identification Of Drug Candidates - A Hot Road To New Drugs
  Fri, 26 February 2010
  The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate...
• Venture Forum To Be Featured At Translational Regenerative Medicine Event
  Thu, 25 February 2010
  A spray-on skin product and an injectable cell therapy for heart attack patients are among 17 regenerative medicine technologies that will be showcased during the Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem...
• Medical News Today And Medilexicon Launch Two Health Forums
  Thu, 25 February 2010
  Medical News Today and Medilexicon are proud to announce the launch of two medical health forums, where health care professionals, patients and lay people may discuss a wide range of medical themes. We invite you to have a look at them...
• Shire Provides Update On Biologics License Application (BLA) Filing For REPLAGAL(R) (aga ...
  Thu, 25 February 2010
  Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces it has received Fast Track designation from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. Shire filed a BLA for REPLAGAL in December 2009...
• Arena Pharmaceuticals Announces FDA Acceptance Of Lorcaserin NDA For Filing
  Thu, 25 February 2010
  Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA)...
• BIO Invites Nominations For The 2010 George Washington Carver Award For Innovation In In ...
  Thu, 25 February 2010
  The third annual George Washington Carver Award will recognize significant contributions by an individual to the field of industrial biotechnology, including applications in biological engineering, environmental science, biorefining and biobased products...
• Biotech Crops Are Top Choice For World's Farmers
  Thu, 25 February 2010
  Because of its contribution to agricultural productivity and sustainable farming, growers around the world continue to choose genetically engineered (GE) crops according to a report released today by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA)...